CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 55 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,835,000 | -66.0% | 466,724 | -47.7% | 0.01% | -66.7% |
| Q3 2017 | $14,229,000 | +15.4% | 892,651 | -12.4% | 0.02% | +15.4% |
| Q2 2017 | $12,330,000 | +9.2% | 1,019,013 | +87.4% | 0.01% | +8.3% |
| Q1 2017 | $11,296,000 | +38.5% | 543,849 | -4.6% | 0.01% | +33.3% |
| Q4 2016 | $8,154,000 | -12.9% | 570,201 | +0.2% | 0.01% | -10.0% |
| Q3 2016 | $9,365,000 | +16.1% | 569,327 | -0.2% | 0.01% | +11.1% |
| Q2 2016 | $8,067,000 | +22.6% | 570,481 | +22.9% | 0.01% | +28.6% |
| Q1 2016 | $6,581,000 | – | 464,132 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $5,961,621 | 2.46% |
| TOWERVIEW LLC | 400,000 | $728,000 | 0.48% |
| Orbimed Advisors | 6,943,654 | $12,637,450 | 0.25% |
| SAMLYN CAPITAL, LLC | 6,123,021 | $11,143,898 | 0.19% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $116,067 | 0.03% |
| Point72 Asset Management, L.P. | 5,964,510 | $10,855,408 | 0.03% |
| Masso Torrence Wealth Management Inc. | 10,000 | $18,200 | 0.01% |
| Hikari Power Ltd | 49,959 | $91 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,300 | $231,686 | 0.01% |
| Quinn Opportunity Partners LLC | 22,327 | $40,635 | 0.01% |